These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 16395266)

  • 1. ACE inhibition reduces glomerulosclerosis and regenerates glomerular tissue in a model of progressive renal disease.
    Remuzzi A; Gagliardini E; Sangalli F; Bonomelli M; Piccinelli M; Benigni A; Remuzzi G
    Kidney Int; 2006 Apr; 69(7):1124-30. PubMed ID: 16395266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of angiotensin II antagonism on the regression of kidney disease in the rat.
    Remuzzi A; Gagliardini E; Donadoni C; Fassi A; Sangalli F; Lepre MS; Remuzzi G; Benigni A
    Kidney Int; 2002 Sep; 62(3):885-94. PubMed ID: 12164870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Podocyte repopulation contributes to regression of glomerular injury induced by ACE inhibition.
    Macconi D; Sangalli F; Bonomelli M; Conti S; Condorelli L; Gagliardini E; Remuzzi G; Remuzzi A
    Am J Pathol; 2009 Mar; 174(3):797-807. PubMed ID: 19164508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ACE inhibition induces regression of proteinuria and halts progression of renal damage in a genetic model of progressive nephropathy.
    Remuzzi A; Fassi A; Bertani T; Perico N; Remuzzi G
    Am J Kidney Dis; 1999 Oct; 34(4):626-32. PubMed ID: 10516341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacologic control of angiotensin II ameliorates renal disease while reducing renal TGF-beta in experimental mesangioproliferative glomerulonephritis.
    Zoja C; Abbate M; Corna D; Capitanio M; Donadelli R; Bruzzi I; Oldroyd S; Benigni A; Remuzzi G
    Am J Kidney Dis; 1998 Mar; 31(3):453-63. PubMed ID: 9506682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ACE inhibition and glomerular repair: restructuring or regeneration?
    Joles JA; Braam B; Verhaar MC
    Kidney Int; 2006 Apr; 69(7):1105-7. PubMed ID: 16609678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the effects of angiotensin-converting enzyme inhibition and angiotensin II receptor blockade on the evolution of spontaneous glomerular injury in male MWF/Ztm rats.
    Remuzzi A; Malanchini B; Battaglia C; Bertani T; Remuzzi G
    Exp Nephrol; 1996; 4(1):19-25. PubMed ID: 8788596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unlike each drug alone, lisinopril if combined with avosentan promotes regression of renal lesions in experimental diabetes.
    Gagliardini E; Corna D; Zoja C; Sangalli F; Carrara F; Rossi M; Conti S; Rottoli D; Longaretti L; Remuzzi A; Remuzzi G; Benigni A
    Am J Physiol Renal Physiol; 2009 Nov; 297(5):F1448-56. PubMed ID: 19675181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The renoprotective properties of angiotensin-converting enzyme inhibitors in a chronic model of membranous nephropathy are solely due to the inhibition of angiotensin II: evidence based on comparative studies with a receptor antagonist.
    Zoja C; Donadelli R; Corna D; Testa D; Facchinetti D; Maffi R; Luzzana E; Colosio V; Bertani T; Remuzzi G
    Am J Kidney Dis; 1997 Feb; 29(2):254-64. PubMed ID: 9016898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Passive Heymann nephritis: evidence that angiotensin-converting enzyme inhibition reduces proteinuria and retards renal structural injury.
    Zoja C; Corna D; Bruzzi I; Foglieni C; Bertani T; Remuzzi G; Benigni A
    Exp Nephrol; 1996; 4(4):213-21. PubMed ID: 8983642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal protective effect of angiotensin-converting enzyme inhibition in aging rats.
    Zoja C; Remuzzi A; Corna D; Perico N; Bertani T; Remuzzi G
    Am J Med; 1992 Apr; 92(4B):60S-63S. PubMed ID: 1580281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blocking angiotensin II ameliorates proteinuria and glomerular lesions in progressive mesangioproliferative glomerulonephritis.
    Nakamura T; Obata J; Kimura H; Ohno S; Yoshida Y; Kawachi H; Shimizu F
    Kidney Int; 1999 Mar; 55(3):877-89. PubMed ID: 10027924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dissociation between antiproteinuric and antihypertensive effect of angiotensin converting enzyme inhibitors in rats.
    Remuzzi A; Imberti O; Puntorieri S; Malanchini B; Macconi D; Magrini L; Bertani T; Remuzzi G
    Am J Physiol; 1994 Dec; 267(6 Pt 2):F1034-44. PubMed ID: 7528985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin converting enzyme inhibition ameliorates glomerular filtration of macromolecules and water and lessens glomerular injury in the rat.
    Remuzzi A; Puntorieri S; Battaglia C; Bertani T; Remuzzi G
    J Clin Invest; 1990 Feb; 85(2):541-9. PubMed ID: 1688888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Candesartan prevents the progression of glomerulosclerosis in genetic hypertensive rats.
    Obata J; Nakamura T; Kuroyanagi R; Yoshida Y; Guo DF; Inagami T
    Kidney Int Suppl; 1997 Dec; 63():S229-31. PubMed ID: 9407467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversal of glomerulosclerosis after high-dose enalapril treatment in subtotally nephrectomized rats.
    Adamczak M; Gross ML; Krtil J; Koch A; Tyralla K; Amann K; Ritz E
    J Am Soc Nephrol; 2003 Nov; 14(11):2833-42. PubMed ID: 14569093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose of doxorubicin determines severity of renal damage and responsiveness to ACE-inhibition in experimental nephrosis.
    Wapstra FH; van Goor H; de Jong PE; Navis G; de Zeeuw D
    J Pharmacol Toxicol Methods; 1999; 41(2-3):69-73. PubMed ID: 10598677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin-converting enzyme inhibition prevents loss of glomerular hydraulic permeability in passive heymann nephritis.
    Remuzzi A; Monaci N; Bonassi ME; Corna D; Zoja C; Mohammed EI; Remuzzi G
    Lab Invest; 1999 Dec; 79(12):1501-10. PubMed ID: 10616201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Addition of AT1 blocker fails to overcome resistance to ACE inhibition in adriamycin nephrosis.
    Bos H; Henning RH; De Boer E; Tiebosch AT; De Jong PE; De Zeeuw D; Navis G
    Kidney Int; 2002 Feb; 61(2):473-80. PubMed ID: 11849387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of combining ACE inhibitor and statin in severe experimental nephropathy.
    Zoja C; Corna D; Rottoli D; Cattaneo D; Zanchi C; Tomasoni S; Abbate M; Remuzzi G
    Kidney Int; 2002 May; 61(5):1635-45. PubMed ID: 11967013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.